Genetic variation in the GCKR gene is associated with non-alcoholic fatty liver disease in Chinese people

Molecular Biology Reports

Volumn 38, Issue 2, 2011, Pages 1145-1150

  Yang, Zhen ^a   Wen, Jie ^a   Tao, Xiaoming ^a   Lu, Bin ^a   Du, Yanping ^a   Wang, Mei ^a   Wang, Xuanchun ^a   Zhang, Weiwei ^a   Gong, Wei ^a   Ling, Charlotte ^b   Wu, Songhua ^c   Hu, Renming ^a  

^a FUDAN UNIVERSITY   (China)

^b LUND UNIVERSITY DIABETES CENTRE   (Sweden)

^c SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

CRP; GCKR; Non alcoholic fatty liver disease; Polymorphism; Triglyceride

Indexed keywords

C REACTIVE PROTEIN; TRIACYLGLYCEROL;

ADULT; ALLELE; ARTICLE; B SCAN; CHINESE; CONTROLLED STUDY; DIET RESTRICTION; DISEASE CLASSIFICATION; DNA POLYMORPHISM; FATTY LIVER; FEMALE; GCKR GENE; GENE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; POPULATION BASED CASE CONTROL STUDY; POPULATION GENETICS; POPULATION RESEARCH; PROTEIN BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AGED; ALLELES; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CHINA; FATTY LIVER; FEMALE; GENE EXPRESSION REGULATION; GENETIC VARIATION; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; TRIGLYCERIDES;

EID: 79951575771     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-010-0212-1     Document Type: Article

References (31)

1. P Angulo 2002 Nonalcoholic fatty liver disease N Engl J Med 346 1221 1231 1:CAS:528:DC%2BD38XivVOmsrY%3D 10.1056/NEJMra011775 11961152 (Pubitemid 34984585)
2. JD Browning LS Szczepaniak R Dobbins P Nuremberg JD Horton JC Cohen SM Grundy HH Hobbs 2004 Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity Hepatology 40 1387 1395 10.1002/hep.20466 10.1002/hep.20466 15565570 (Pubitemid 39657013)
3. M Shibata Y Kihara M Taguchi M Tashiro M Otsuki 2007 Nonalcoholic fatty liver disease is a risk factor for type 2 diabetes in middle-aged Japanese men Diabetes Care 30 2940 2944 10.2337/dc07-0792 1:CAS:528:DC%2BD2sXhtlKhs7vF 10.2337/dc07-0792 17666460 (Pubitemid 350083148)
4. G Targher L Bertolini R Padovani S Rodella R Tessari L Zenari C Day G Arcaro 2007 Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients Diabetes Care 30 1212 1218 10.2337/dc06-2247 10.2337/dc06-2247 17277038 (Pubitemid 46684650)
5. P Angulo 2007 GI epidemiology: nonalcoholic fatty liver disease Aliment Pharmacol Ther 25 883 889 10.1111/j.1365-2036.2007.03246.x 1:STN:280: DC%2BD2s3gtVyrtA%3D%3D 10.1111/j.1365-2036.2007.03246.x 17402991
6. R Williams 2006 Global challenges in liver disease Hepatology 44 521 526 10.1002/hep.21347 10.1002/hep.21347 16941687 (Pubitemid 44433707)
7. JG Fan J Zhu XJ Li L Chen L Li F Dai F Li SY Chen 2005 Prevalence of and risk factors for fatty liver in a general population of Shanghai, China J Hepatol 43 508 514 10.1016/j.jhep.2005.02.042 10.1016/j.jhep.2005.02.042 16006003 (Pubitemid 41111434)
8. YJ Zhou YY Li YQ Nie JX Ma LG Lu SL Shi MH Chen PJ Hu 2007 Prevalence of fatty liver disease and its risk factors in the population of South China World J Gastroenterol 13 6419 6424 10.3748/wjg.13.6419 10.3748/wjg.13.6419 18081233
9. FG Toledo AD Sniderman DE Kelley 2006 Influence of hepatic steatosis (fatty liver) on severity and composition of dyslipidemia in type 2 diabetes Diabetes Care 29 1845 1850 10.2337/dc06-0455 10.2337/dc06-0455 16873790 (Pubitemid 44156640)
10. K Kantartzis K Rittig A Cegan J Machann F Schick B Balletshofer A Fritsche E Schleicher HU Haring N Stefan 2008 Fatty liver is independently associated with alterations in circulating HDL2 and HDL3 subfractions Diabetes Care 31 366 368 10.2337/dc07-1558 1:CAS:528:DC%2BD1cXis1ajs7g%3D 10.2337/dc07-1558 18000185 (Pubitemid 351213353)
11. H Tilg GS Hotamisligil 2006 Nonalcoholic fatty liver disease: cytokine-adipokine interplay and regulation of insulin resistance Gastroenterology 131 934 945 10.1053/j.gastro.2006.05.054 1:CAS:528: DC%2BD28XhtVKrurbP 10.1053/j.gastro.2006.05.054 16952562 (Pubitemid 44307061)
12. A Kotronen H Yki-Jarvinen 2008 Fatty liver: a novel component of the metabolic syndrome Arterioscler Thromb Vasc Biol 28 27 38 10.1161/ATVBAHA.107. 147538 1:CAS:528:DC%2BD2sXhsVeiu7nI 10.1161/ATVBAHA.107.147538 17690317
13. X Yuan D Waterworth JR Perry N Lim K Song JC Chambers W Zhang P Vollenweider H Stirnadel T Johnson S Bergmann ND Beckmann Y Li L Ferrucci D Melzer D Hernandez A Singleton J Scott P Elliott G Waeber L Cardon TM Frayling JS Kooner V Mooser 2008 Population-based genome-wide association studies reveal six loci influencing plasma levels of liver enzymes Am J Hum Genet 83 520 528 10.1016/j.ajhg.2008.09.012 1:CAS:528:DC%2BD1cXht1OmtbrM 10.1016/j.ajhg.2008.09. 012 18940312
14. S Romeo J Kozlitina C Xing A Pertsemlidis D Cox LA Pennacchio E Boerwinkle JC Cohen HH Hobbs 2008 Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease Nat Genet 40 1461 1465 10.1038/ng.257 1:CAS:528:DC%2BD1cXhsVWgsrrP 10.1038/ng.257 18820647
15. E Van Schaftingen M Detheux M Veiga da Cunha 1994 Short-term control of glucokinase activity: role of a regulatory protein FASEB J 8 414 419 8168691 (Pubitemid 24155954)
16. D Farrelly KS Brown A Tieman J Ren SA Lira D Hagan R Gregg KA Mookhtiar N Hariharan 1999 Mice mutant for glucokinase regulatory protein exhibit decreased liver glucokinase: a sequestration mechanism in metabolic regulation Proc Natl Acad Sci USA 96 14511 14516 1:CAS:528:DyaK1MXnvFKks70%3D 10.1073/pnas.96.25. 14511 10588736 (Pubitemid 30000681)
17. J Grimsby JW Coffey MT Dvorozniak J Magram G Li FM Matschinsky C Shiota S Kaur MA Magnuson JF Grippo 2000 Characterization of glucokinase regulatory protein-deficient mice J Biol Chem 275 7826 7831 10.1074/jbc.275.11.7826 1:CAS:528:DC%2BD3cXitVylsbg%3D 10.1074/jbc.275.11.7826 10713097 (Pubitemid 30159689)
18. Diabetes Genetics Initiative of Broad Institute of Harvard and MIT, Lund University, and Novartis Institutes of BioMedical Research 2007 Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels Science 316 1331 1336 10.1126/science.1142358 (Pubitemid 46871653)
19. PM Ridker G Pare A Parker RY Zee JS Danik JE Buring D Kwiatkowski NR Cook JP Miletich DI Chasman 2008 Loci related to metabolic-syndrome pathways including LEPR, HNF1A, IL6R, and GCKR associate with plasma C-reactive protein: the Women's Genome Health Study Am J Hum Genet 82 1185 1192 10.1016/j.ajhg.2008. 03.015 1:CAS:528:DC%2BD1cXlvFeqt7c%3D 10.1016/j.ajhg.2008.03.015 18439548
20. H Shi MV Kokoeva K Inouye I Tzameli H Yin JS Flier 2006 TLR4 links innate immunity and fatty acid-induced insulin resistance J Clin Invest 116 3015 3025 10.1172/JCI28898 1:CAS:528:DC%2BD28XhtFyrsLfE 10.1172/JCI28898 17053832 (Pubitemid 44684486)
21. Q Qi Y Wu H Li RJ Loos FB Hu L Sun L Lu A Pan C Liu H Wu L Chen Z Yu X Lin 2009 Association of GCKR rs780094, alone or in combination with GCK rs1799884, with type 2 diabetes and related traits in a Han Chinese population Diabetologia 52 834 843 10.1007/s00125-009-1290-2 1:CAS:528:DC%2BD1MXktVOkuro%3D 10.1007/s00125-009-1290-2 19241058
22. SH Saverymuttu AE Joseph JD Maxwell 1986 Ultrasound scanning in the detection of hepatic fibrosis and steatosis Br Med J (Clin Res Ed) 292 13 15 10.1136/bmj.292.6512.13 1:STN:280:DyaL287gsV2msA%3D%3D 10.1136/bmj.292.6512.13 (Pubitemid 16175875)
23. AE Joseph SH Saverymuttu S al-Sam MG Cook JD Maxwell 1991 Comparison of liver histology with ultrasonography in assessing diffuse parenchymal liver disease Clin Radiol 43 26 31 10.1016/S0009-9260(05)80350-2 1:STN:280: DyaK3M7lt12ksQ%3D%3D 10.1016/S0009-9260(05)80350-2 1999069
24. DR Matthews JP Hosker AS Rudenski BA Naylor DF Treacher RC Turner 1985 Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 412 419 10.1007/BF00280883 1:CAS:528:DyaL2MXlslKnu7k%3D 10.1007/BF00280883 3899825 (Pubitemid 15018832)
25. J Wen T Rönn A Olsson Z Yang B Lu Y Du L Groop C Ling R Hu 2010 Investigation of type 2 diabetes risk alleles support CDKN2A/B, CDKAL1, and TCF7L2 as susceptibility genes in a Han Chinese cohort PLoS One 5 e9153 10.1371/journal.pone.0009153 10.1371/journal.pone.0009153 20161779
26. M Orho-Melander O Melander C Guiducci P Perez-Martinez D Corella C Roos R Tewhey MJ Rieder J Hall G Abecasis ES Tai C Welch DK Arnett V Lyssenko E Lindholm R Saxena PI de Bakker N Burtt BF Voight JN Hirschhorn KL Tucker T Hedner T Tuomi B Isomaa KF Eriksson MR Taskinen B Wahlstrand TE Hughes LD Parnell CQ Lai G Berglund L Peltonen E Vartiainen P Jousilahti AS Havulinna V Salomaa P Nilsson L Groop D Altshuler JM Ordovas S Kathiresan 2008 Common missense variant in the glucokinase regulatory protein gene is associated with increased plasma triglyceride and C-reactive protein but lower fasting glucose concentrations Diabetes 57 3112 3121 10.2337/db08-0516 1:CAS:528: DC%2BD1MXhsleis7Y%3D 10.2337/db08-0516 18678614
27. P van der Harst SJ Bakker RA de Boer BH Wolffenbuttel T Johnson MJ Caulfield G Navis 2010 Replication of the five novel loci for uric acid concentrations and potential mediating mechanisms Hum Mol Genet 19 387 395 10.1093/hmg/ddp489 10.1093/hmg/ddp489 19861489
28. Y Horikawa K Miyake K Yasuda M Enya Y Hirota K Yamagata Y Hinokio Y Oka N Iwasaki Y Iwamoto Y Yamada Y Seino H Maegawa A Kashiwagi K Yamamoto K Tokunaga J Takeda M Kasuga 2008 Replication of genome-wide association studies of type 2 diabetes susceptibility in Japan J Clin Endocrinol Metab 93 3136 3141 10.1210/jc.2008-0452 1:CAS:528:DC%2BD1cXpvVOls70%3D 10.1210/jc.2008-0452 18477659
29. JE Gerich 1993 Control of glycaemia Baillieres Clin Endocrinol Metab 7 551 586 10.1016/S0950-351X(05)80207-1 1:STN:280:DyaK3szptlGhsA%3D%3D 10.1016/S0950-351X(05)80207-1 8379904 (Pubitemid 23243426)
30. Floettmann E, Gregory L, Teague J, Myatt J, Hammond C, Poucher SM, Jones HB (2010) Prolonged inhibition of glycogen phosphorylase in liver of zucker diabetic fatty rats models human glycogen storage diseases. Toxicol Pathol. [Epub ahead of print] doi: 10.1177/0192623310362707
31. KL Donnelly CI Smith SJ Schwarzenberg J Jessurun MD Boldt EJ Parks 2005 Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease J Clin Invest 115 1343 1351 10.1172/JCI200523621 1:CAS:528:DC%2BD2MXktFSktLk%3D 15864352 (Pubitemid 40629054)